MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Phase 3
Completed
Conditions
Myocardial Infarction
Coronary Disease
Myocardial Ischemia
Heart Failure
Hypercholesterolemia
Diabetes Mellitus
Hypertension
Cardiovascular Diseases
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000542

PATHWAYS--FULL SCALE STUDY

Phase 2
Completed
Conditions
Obesity
Cardiovascular Diseases
Sedentary Behaviors
First Posted Date
1999-10-28
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000545

Emphysema: Physiologic Effects of Nutritional Support

Phase 2
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Lung Diseases, Obstructive
Emphysema
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-05-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000573

Asymptomatic Carotid Artery Plaque Study (ACAPS)

Phase 2
Completed
Conditions
Carotid Stenosis
Cerebrovascular Disorders
Cerebral Arteriosclerosis
Cardiovascular Diseases
Vascular Diseases
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-05-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000469

T-Cell Depletion in Unrelated Donor Marrow Transplantation

Phase 3
Completed
Conditions
Myelodysplastic Syndromes
Bone Marrow Transplantation
Leukemia
Graft vs Host Disease
Immunologic Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000591

Clinical Study of Intermittent Positive Pressure Breathing (IPPB)

Phase 3
Completed
Conditions
Lung Diseases
Chronic Obstructive Pulmonary Disease
Lung Diseases, Obstructive
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000565

Cord Blood Stem Cell Transplantation Study (COBLT)

Phase 2
Completed
Conditions
Hematologic Diseases
Hematopoietic Stem Cell Transplantation
Myelodysplastic Syndromes
Anemia, Aplastic
Fanconi Anemia
Leukemia
Severe Combined Immunodeficiency
Neoplasms
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000603

Dietary Approaches to Stop Hypertension (DASH)

Phase 3
Completed
Conditions
Vascular Diseases
Heart Diseases
Hypertension
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-11-06
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000544

Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)

Phase 2
Completed
Conditions
Hematologic Diseases
Anemia, Sickle Cell
Hemoglobinopathies
First Posted Date
1999-10-28
Last Posted Date
2016-09-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000602

NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy

Phase 3
Completed
Conditions
Asthma
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000578
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy